Volume 3 - Issue 2 - March/April 2006

Frank J. Criado, MD

After completing a review of the article “Management of Detached Accunet…” by Chane et al., I found myself wanting to add something personal, a commentary. So I did, but it wasn’t enough. I therefore decided to reflect further upon our field’s “… | Read More

David E. Allie, MD, Chris J. Hebert, RT, RCIS and Craig M. Walker, MD

Case Study D.T., a 78-year-old, black female, presented electively for a redo right renal percutaneous transluminal angioplasty (PTA) after canceling 3 weeks prior, due to the ravages of Hurricanes Katrina and Rita in Louisiana. She noted vague… | Read More

Majed Chane, MD, Abe Ballard, CVT, Angela Vanpatten, RN, Richard Heuser, MD

Introduction Carotid artery angioplasty and stenting (CAS) has gained acceptance in the past decade as an alternative strategy for management of carotid artery stenosis. The recent SAPPHIRE trial1 has shown that, in high surgical risk patients, CAS… | Read More

<p>Jaffar Ali Raza, MD, Michael Miller, MD, •Robert S. Dieter, MD, RVT, ••Leonardo C. Clavijo, MD, Michael C. Stoner, MD, Aravinda Nanjundappa, MD</p>

Introduction Mesenteric ischemia is an uncommon but serious disease. It was reported by Conner in 1933, who postulated that patients with chronic abdominal pain may have actually suffered from repeated intestinal angina.1 Mesenteric ischemia can be… | Read More

Richard F. Neville, MD, David Deaton, MD, James Laredo, MD, PhD

Background As the population ages, an increasing number of patients are in need of lower extremity revascularization. Improvements in surgical, anesthetic, and endovascular techniques provide an increasingly aggressive approach to limb salvage that… | Read More

Jeffrey L. Ballard, MD

Introduction Successful treatment of symptomatic varicose veins requires a balance between treatment of the underlying etiology and achievement of an optimal cosmetic outcome. In the overwhelming majority of cases, saphenous vein reflux is the… | Read More

A. Frederick Schild, MD and Erin Gillaspie, BS

Introduction End-stage renal disease (ESRD) is increasing in epidemic proportions worldwide. Therefore, vascular access procedures are rapidly becoming the most common surgery performed in the world. In the United States, there are approximately… | Read More

Nicolas W. Shammas, MS, MD

Clinical Pharmacology of Bivalirudin Bivalirudin is a direct thrombin inhibitor with specific and reversible actions.1–6 It is a synthetic, 20-amino acid peptide with a molecular weight of 2180 daltons. Bivalirudin directly inhibits both circulating… | Read More